Hong Zhu

Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial

Shukui Qin, Zhenggang Ren, Zhiqiang Meng et al. · The Lancet Oncology · 2020 · 638 citations

Medicine, Oncology, Pharmacology +9

A Phase I dose-escalation, pharmacokinetics and food-effect study of oral donafenib in patients with advanced solid tumours

Xiaoyu Li, Meng Qiu, Shengjun Wang et al. · Cancer Chemotherapy and Pharmacology · 2020 · 58 citations

Pharmacy, Oncology, Pharmacokinetics +9

Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions

Wenhua Li, Dongye Li, Fei Han et al. · International Urology and Nephrology · 2012 · 43 citations · Full text

Medicine, Cardiology, Hematology +14

Pain Prevalence and Pain Management in a Chinese Hospital

Hong Xiao, Hui Liu, Jin Liu et al. · Medical Science Monitor · 2018 · 36 citations · Full text

Medicine, Internal Medicine, Hospital Medicine +7

Impact of the National Reimbursement Drug List Negotiation Policy on Accessibility of Anticancer Drugs in China: An Interrupted Time Series Study

Hong Zhu, Jingmin Zhu, Yingyu Zhou et al. · Frontiers in Public Health · 2022 · 35 citations · Full text

Pharmacy, Pharmaceutical Policy, Drug Approval Processes +9